UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 8-K

Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) November 12, 2015

Dynasil Corporation of America
(Exact name of registrant as specified in its charter)

 Delaware                   000-27503                22-1734088
-----------               ---------------          -------------
(State or other           (Commission              (IRS Employer
jurisdiction               File Number)         Identification No.)
of incorporation)

313 Washington Street, Suite 403, Newton, MA 02458
(Address of principal executive offices)

(617)-668-6855
(Registrant's telephone number, including area code)

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d- 2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e- 4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 5.02 Departure of Directors or Certain Officers;
Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On November 13, 2015, Dynasil Corporation of America ("Dynasil" or the "Company") announced the planned succession of the Company's senior financial leadership. Thomas C. Leonard, the Company's current Chief Financial Officer, notified the Board on November 12, 2015 that he will retire from the Company effective January 31, 2016. Mr. Leonard will be succeeded by Robert J. Bowdring, the Company's current Corporate Controller, who has accepted the position of Chief Financial Officer, effective February 1, 2016.

Mr. Bowdring, 58, has served as Corporate Controller for the Company since March of 2013. Additionally, he brings over 35 years of accounting and financial experience to his new position. Prior to joining Dynasil, Mr. Bowdring served as the Chief Financial Officer for INVO Bioscience, a publicly traded development-stage infertility medical device company based in Medford, Massachusetts, from 2008 until 2013. He continues as a member of the Board of Directors of INVO Bioscience. He also served as Chief Financial Officer of Cyphermint, Inc. from 2003 to 2008, and as Vice President and Corporate Controller for Lifeline Systems from 1989 to 2003. Prior to 1989, Mr. Bowdring held positions of increasing responsibility at Remanco, Inc., Warburton's Inc., Cyborg Corporation, and Technogenics, Inc. Mr. Bowdring has a B.A. in Accounting from the University of Massachusetts.

On November 12, 2015, Dynasil and Mr. Bowdring entered into an Employment Letter (the "Employment Letter"), which provides that he will assume the role of Chief Financial Officer on February 1, 2016 (the "Start Date"). Under the Employment Letter, Mr. Bowdring will earn an annual base salary of $185,000, which is subject to periodic review and adjustment. For each fiscal year during his employment, Mr. Bowdring will be eligible to earn an annual cash performance bonus of up to twenty-five (25%) percent of his then current base salary under terms and conditions to be determined by the Chief Executive Officer and approved by the Compensation Committee of the Board of Directors.

On or near the Start Date, Mr. Bowdring will be granted a restricted stock award of 60,000 shares of the Company's common stock. This grant will vest as to 33.3% of the shares on each annual anniversary of the Start Date, provided, that Mr. Bowdring is employed with the Company continuously through the applicable vesting date.

Mr. Bowdring's employment is at-will. If Mr. Bowdring is terminated without "cause" (as such term is defined in the Employment Letter), he will be entitled to a severance payment of (i) three months of base salary if the termination occurs within eighteen (18) months of the Start Date; or (ii) six months of base salary if the severance occurs after eighteen (18) months from the Start Date, subject to his executing a general release in favor of the Company.

The foregoing description of the Employment Letter is qualified in its entirety by reference to the complete text of the Employment Letter filed as Exhibit 10.1 to this Form 8-K, which is incorporated herein by reference.

ITEM 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit 10.1 Employment Letter between the Company and Robert J. Bowdring, dated November 12, 2015

Exhibit 99.1 Press release, dated November 13, 2015, issued by the Company


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

DYNASIL CORPORATION OF AMERICA

Date: November 13, 2015     By:  /s/ Peter Sulick
                                ---------------------------

                                         Peter Sulick
                                         President and CEO


EXHIBIT INDEX

Exhibit 10.1 Employment Letter between the Company and Robert J. Bowdring, dated November 13, 2015

Exhibit 99.1 Press release, dated November 13, 2015, issued by the Company


[LOGO]Dynasil

November 12, 2015

Mr. Robert Bowdring

Re: Employment with Dynasil Corporation of America

Dear Rob:

It is with great pleasure that I write to confirm the terms under which you will be promoted and continue to be employed with Dynasil Corporation of America (the "Company"). We look forward to your continued leadership in your new role. The principal terms of your employment are set forth in this letter ("Letter").

1. Start Date. Your promotion will become effective on February 1, 2016 upon Tom Leonard's retirement.

2. Title; Duties. You will hold the title of Chief Financial Officer of the Company. You will perform such duties as are inherent in such position and such other duties as may be assigned by the Company from time to time. You will be subject to the direction and supervision of the Chief Executive Officer. You agree to serve the Company diligently and faithfully so as to advance the Company's best interests and agree to not take any action in conflict with the Company's best interests.

3. At-Will Employment. At all times, your employment with the Company will be at-will employment which may be terminated by you or the Company at any time, with or without Cause and with or without advance notice. Upon any such termination, except as set forth in
Section 5 of this Letter, the Company will have no liability or obligation to make any payment or provide any benefits to you (including, without limitation, any salary or bonus payments or benefits described in
Section 4) or to your executors, legal representatives, administrators, heirs or assigns or any other person claiming under or through you, except those required by law. Your at-will employment may be modified only in writing as detailed in a duly-adopted Board resolution.

4. Compensation; Benefits.

(a) Base Salary. You will receive a base salary during your employment at rate of $15,416.66 per month (which is equivalent to $185,000 on an annualized basis), payable in accordance with the Company's usual payment practices and subject to periodic review and, in its sole discretion, adjustment by the Company.


(b) Annual Bonus. In each fiscal year during your employment beginning with fiscal year 2016, you will be eligible to earn an annual cash performance bonus of up to twenty (25%) percent of your then current Base Salary ("Target Bonus") under terms and conditions to be determined by the Chief Executive Officer in discussions with you and approved by the Compensation Committee of the Board prior to the start of each fiscal year. The award of any annual bonus will be in the Company's sole discretion. The annual bonus, if any, will be payable after receipt of the Company's audited financial statements for such fiscal year.

(c) Equity. Subject to the approval of the Company's Board of Directors ("Board"), you will be granted a time-vested restricted stock award of 60,000 shares ("Time-Based Grant") of the Company's common stock, $0.0005 par value ("Common Stock"). The Time-Based Grant will be made under the Company's 2010 Stock Incentive Plan at no cost to you though you shall be responsible for payment of taxes on the fair market value of the shares as they vest to you. The Time-Based Grant will vest in accordance with the following schedule:

(i) 1/3 (33.3%) per annum on the employment anniversary date.

Further terms and conditions, if any, to be determined by the Board.

(d) Benefits. During your employment, you will be eligible to participate in all employee benefit plans and perquisite plans and policies (including fringe benefits, 401(k) plan participation, life, health, dental, accident and short and long term disability insurance) which the Company may, in its sole discretion, make available to its similarly-situated employees, whether such benefits are now in effect or hereafter adopted, subject to the terms and conditions of each such plan or policy. Subject to applicable law, the Company may alter, modify, add to or delete its employee benefit plans and its perquisite plans and policies at any time as it, in its sole judgment, determines to be appropriate, without recourse by you.

(e) Vacation. You will receive twenty (20) days of paid vacation time per calendar year during your employment (pro-rated for partial years), which will accrue and may be used according to Company policy as in effect from time to time. Notwithstanding the terms of any Company policy to the contrary, your unused vacation time will not carry over from one calendar year to the next.

(f) Reimbursement for Expenses. You will receive reimbursement from the Company for expenses that you reasonably incur on behalf of the Company in accordance with the Company's normal policies with respect to expense reimbursements. Notwithstanding the foregoing, it is agreed that the company will pay or reimburse your mobile phone up to the level of $100 per month.

(g) Deductions and Withholdings. Notwithstanding any other provision of this Letter, any payments or benefits from the Company to you will be subject to the withholding of such amounts, if any, relating to tax and other payroll deductions, as the Company reasonably determines it should withhold pursuant to any applicable law or regulation.

-2-

5. Severance.

(a) Severance Package. If the Company terminates your employment without Cause (as defined in this Section), and provided that you first deliver to the Company an irrevocable separation agreement in a form and of a scope reasonably acceptable to the Company (which will include a general release of claims among other terms) within sixty (60) days of the effective date of your separation, the Company will provide you with a severance payment (the "Severance Payment") as follows:

(i) If the separation date occurs within eighteen (18) months after the Start Date, a payment in the gross amount of three months of your then-current Base Salary, paid in substantially equal installments over a period of 3 months according to the Company's regular payroll schedule, beginning 60 days after the separation date; or

(ii) If the separation date occurs more than 18 months after the Start Date, a payment in the gross amount of six months of your then Base Salary, paid in substantially equal installments over a period of 6 months according to the Company's regular payroll schedule, beginning 60 days after the separation date.

As an additional condition of the Severance Package, you agree to make yourself reasonably available to answer questions by telephone during the period from the separation date through the end of any period in which you are receiving the Severance Payment.

(b) Cause Definition.

(i) For purposes of this Letter, "Cause" means any of the following:

(A) You materially breach any duty or obligation owed to the Company, under
this Letter or the Dynasil Confidential
Information and Invention Assignment
Agreement, or the rules and regulations
of the Company and such violation, if
susceptible to cure in the Company's
reasonable judgment, is not cured to
the Company's reasonable satisfaction
within fifteen (15) days after written
notice thereof is provided to you;

(B) You refuse or are unwilling to perform any of the duties assigned by the
Company in good faith, after a written
request from the Company to do so, and
such refusal or unwillingness, if
susceptible to cure in the Company's
reasonable judgment, is not cured to
the Company's reasonable satisfaction
within fifteen (15) days after written
notice thereof is provided to you;

(C) You are convicted by a court of competent jurisdiction of, or plead guilty or nolo contendere to, any felony or any crime involving moral turpitude;

-3-

(D) You engage in conduct that would tend to bring public disrespect, contempt or
ridicule to the Company, as reasonably
determined in good faith by the
Company) and such conduct, if
susceptible to cure in the Company's
reasonable judgment, is not cured to
the Company's reasonable satisfaction
within fifteen (15) days after written
notice thereof is provided to you; or
you are repeatedly absent from work
(excluding vacations, illnesses,
disability leaves, or other leaves of
absence approved by the Company) and
such absence is not corrected within
fifteen (15) days after written notice
thereof is provided to you;

6. Death or Disability. If you die or become totally and permanently disabled during the term of employment, the parties agree that the employment relationship and this Letter will terminate automatically. "Total disability" means your inability, resulting from sickness, disease, injury or physical or mental illness, to perform in all material respects all of the services pertaining to your employment under this Letter, with or without reasonable accommodation. Such total disability will be deemed "permanent" if you have not recovered and returned to render the full services of his employment hereunder within six (6) months of becoming totally disabled. You will not be eligible for any Severance Payment if your employment is terminated under this paragraph.

7. Section 409A. The intent of the parties is that payments and benefits under this Agreement comply with Internal Revenue Code Section 409A and the regulations and guidance promulgated thereunder (collectively "Code Section 409A") and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in compliance therewith. To the extent that any provision hereof is modified in order to comply with Code Section 409A, such modification shall be made in good faith and shall, to the maximum extent reasonably possible, maintain the original intent and economic benefit to you and the Company of the applicable provision without violating the provisions of Code
Section 409A. A termination of employment shall not be deemed to have occurred for purposes of any provision of this Agreement providing for the payment of any amounts or benefits upon or following a termination of employment unless such termination is also a "separation from service" within the meaning of Code Section 409A and, for purposes of any such provision of this Agreement, references to a "termination," "termination of employment" or like terms shall mean "separation from service." If you are deemed on the date of termination to be a "specified employee" within the meaning of that term under Code Section 409A(a)(2)(B), then with regard to any payment or the provision of any benefit that is considered deferred compensation under Code Section 409A payable on account of a "separation from service," such payment or benefit shall be made or provided at the date which is the earlier of (A) the expiration of the six (6)-month period measured from the date of your "separation from service," and (B) the date of your death, to the extent required under Code Section 409A. Upon the expiration of the foregoing delay period, all payments and benefits delayed pursuant to this subsection (whether they would have otherwise been payable in a single sum or in installments in the absence of such delay) shall be paid or reimbursed to you in a lump sum, and any remaining payments and benefits due under this Agreement shall be paid or provided in accordance with the normal payment dates specified for them herein. For purposes of Code Section 409A, your right to receive any installment payments pursuant to this Agreement shall be treated as a right to receive a series of separate and distinct payments.

-4-

8. Confidential Information and Invention Assignment Letter. As a condition of your employment, you will sign, and be bound by, the "Dynasil Confidential Information and Invention Assignment Letter," a copy of which is enclosed with this Letter.

9. Return of Company Property. You agree that upon the termination or cessation of your employment with the Company for any reason (whether initiated by you or by the Company), or at any other time upon the Company's request, you will immediately return to the Company all Company property of any kind then in your possession or under your control, including, without limitation, the originals and all copies of any and all documents, files or records (including computer data, disks, programs, or printouts) that contain any non-public information that in any way relates to the Company, any of its subsidiaries or affiliates, any of their products or services, clients, suppliers or other aspects of any of their business(es) or prospects, all other notes, drawings, lists, memoranda, magnetic disks or tapes, other recording media, reports, files, memoranda, software, credit cards, door and file keys, telephones, PDAs, computers, computer access codes, instructional manuals, and any other physical property that you received, prepared, or helped prepare in connection with your employment. You further agree to not retain any copies, summaries or excerpts of any such property in any format, whether hardcopy, electronic or otherwise. To the extent that you have Company property stored on any home computer(s) or other personal storage device(s), you agree to forward a copy of any such property to a designated Company official and then irretrievably delete all such property from your personal home computer(s) and any other personal electronic device(s) at the same time that you return all tangible property to the Company.

10. Notices. Any notice hereunder by either Party to the other will be given in writing by personal delivery, telex, facsimile, overnight courier or certified mail, return receipt requested, addressed, if to the Company, to the attention of the Chief Executive Officer (or such other person as the Company may designate) at Dynasil Corporation of America, 313 Washington Street Newton, MA 02458 or to such other address as the Company may designate in writing at any time or from time to time to you, and if to you, to your most recent address on file with the Company. Notice will be deemed given, if by personal delivery or by overnight courier, on the date of such delivery or, if by telex or facsimile, on the business day following receipt of answer back or facsimile information or, if by certified mail, on the date shown on the applicable return receipt.

11. Continuing Obligations. Your obligations under Sections 8 through 10 of this Letter, inclusive, will survive any change in your employment status with the Company, by promotion or otherwise, and the termination or cessation of your employment with Company for any reason. The Company's obligations under this Letter will be binding on successors to the Company.

12. Severability. If any arbitrator, agency, tribunal or court of competent jurisdiction finds any provision or part of this Letter to be excessively broad, in whole or in part, such provision will be deemed and construed to be reduced to the maximum duration, scope or subject matter allowable under applicable law. If any provision or part of this Letter is declared illegal or unenforceable by any arbitrator, tribunal or court of competent jurisdiction even after the reformation and construction as provided in the previous sentence, then the remainder of this Letter, or the application of such provision or part in circumstances other than those as to which it is so declared illegal or unenforceable, will not be affected thereby, and each provision and part of this Letter will be valid and enforceable to the fullest extent permitted by law.

-5-

13. Governing Law. This Letter will be governed by, construed and enforced in accordance with, the laws of Massachusetts, without regard to conflict of laws principles.

14. Counterparts. This Letter may be executed in any number of counterparts, any one of which will constitute an original of this Letter, provided that this Letter will not become effective until each party has executed at least one counterpart. The parties agree that signatures on separate counterparts may be transferred to a single document upon the request of any party. For the convenience of the parties, facsimile, pdf or other electronic signatures will be accepted as originals.

If the terms of this Agreement are acceptable to you, please sign the enclosed copy of this letter where indicated and return to me. Once again, the Company is grateful for your willingness to undertake these duties and I look forward to working with you.
Sincere congratulations on a well-deserved promotion.

/s/ Peter Sulick
_____________________________
Peter Sulick
Chairman, Chief Executive Officer

AGREED AND ACCEPTED:

/s/ Robert Bowdring
_____________________________
Robert J. Bowdring


[LOGO] Dynasil

Contacts:
Patty Kehe
Dynasil Corporation of America
Phone: 617.668.6855
Email: pkehe@dynasil.com

Dynasil Announces Retirement of CFO Thomas Leonard; Corporate Controller Robert Bowdring Named as Successor

NEWTON, Mass. - November 13, 2015 - Dynasil Corporation of America ("Dynasil" or the "Company") (NASDAQ: DYSL), a developer and manufacturer of optics and photonics products, optical detection and analysis technology and components for the homeland security, medical and industrial markets, today announced the planned succession of the Company's senior financial leadership. Thomas C. Leonard, chief financial officer ("CFO"), has decided to retire, effective January 31, 2016. Robert J. Bowdring, the Company's current corporate controller, will assume the CFO position on February 1, 2016. Both Mr. Leonard and Mr. Bowdring joined Dynasil in 2013.

"We are very grateful for the strong financial leadership that Tom provided Dynasil for the last three years," said Peter Sulick, President and CEO. "During his time with the Company, Tom led Dynasil through some important financial milestones and was instrumental in restoring our favorable credit and banking relationships."

Prior to joining Dynasil, Mr. Bowdring served as the CFO for INVO Bioscience, a publicly traded development-stage infertility medical device company based in Medford, MA, from 2008 until 2013. He continues as a member of the Board of Directors of INVO Bioscience. He also served CFO of Cyphermint, Inc. from 2003 to 2008, and as Vice President and Corporate Controller for Lifeline Systems from 1989 to 2003. Prior to 1989, Mr. Bowdring held positions of increasing responsibility at Remanco, Inc., Warburton's Inc., Cyborg Corporation, and Technogenics, Inc. Mr. Bowdring has a B.A. in Accounting from the University of Massachusetts.

"We expect a seamless transition of Rob to CFO. Rob's three years of experience on the Dynasil corporate financial team and his knowledge of the financial workings of Dynasil will serve the Company well", continued Mr. Sulick.


About Dynasil
Dynasil Corporation of America (NASDAQ: DYSL) develops and manufactures optical detection and analysis technology and components for the homeland security, medical and industrial markets. Combining world-class expertise in research and materials science with extensive experience in manufacturing and product development, Dynasil is commercializing products including dual-mode radiation detection solutions for Homeland Security and commercial applications and sensors for non-destructive testing. Dynasil has an impressive and growing portfolio of issued and pending U.S. patents. The Company is based in Watertown, Massachusetts, with additional operations in Mass., Minn., NY, NJ and the United Kingdom. More information about the Company is available at www.dynasil.com.

Forward-Looking Statements

This press release contains statements which are not historical facts and which constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may be identified by the use of words such as "may," "could," "expect," "estimate," "anticipate," "continue" or similar terms, though not all forward-looking statements contain such words. These forward-looking statements are based on current expectations, estimates, forecasts, and projections and the beliefs and assumptions of our management. Examples of forward-looking statements include, but are not limited to those related to Robert Bowdring's appointment as CFO. The actual results of the future events described in such forward looking statements could differ materially from those stated in such forward looking statements due to a number of important factors. These factors that could cause actual results to differ from those anticipated or predicted include, but are not limited to, continuation of existing market conditions, the demand for our products, the borrowing availability under our line of credit or the absence thereof, our ability to obtain and maintain intellectual property protection for our products, competition, the loss of key management and technical personnel, and the uncertainties set forth in the Company's 2014 Annual Report on Form 10 K, filed December 16, 2014, including the risk factors contained in Item 1a, the Company's Quarterly Reports on Form 10-Q filed on February 17, 2015, May 13, 2015 and August 12, 2015 and from time to time in the Company's other filings with the Securities and Exchange Commission. The Company disclaims any intention or obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.